Phase II Trial of Doxorubicin and Paclitaxel Plus Granulocyte Colony-Stimulating Factor in Metastatic Breast Cancer: An Eastern Cooperative Oncology Group Study PURPOSE: The European Association of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback